Home Other Building Blocks Erythromycin Cyclocarbonate

Erythromycin Cyclocarbonate

CAS No.:
55224-05-0
Catalog Number:
AG01DQ6Z
Molecular Formula:
C38H65NO14
Molecular Weight:
759.9210
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$133
- +
2mg
98%
1 week
United States
$223
- +
5mg
≥98%
1 week
United States
$286
- +
10mg
≥98%
1 week
United States
$439
- +
25mg
≥98%
1 week
United States
$689
- +
Product Description
Catalog Number:
AG01DQ6Z
Chemical Name:
Erythromycin Cyclocarbonate
CAS Number:
55224-05-0
Molecular Formula:
C38H65NO14
Molecular Weight:
759.9210
MDL Number:
MFCD01729176
IUPAC Name:
(1R,2R,5R,6S,7S,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-hydroxy-6-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,5,7,9,11,13-hexamethyl-3,15,17-trioxabicyclo[12.3.0]heptadecane-4,12,16-trione
InChI:
InChI=1S/C38H65NO14/c1-14-25-38(10)32(52-35(44)53-38)20(4)27(40)18(2)16-36(8,45)31(51-34-28(41)24(39(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-37(9,46-13)30(42)23(7)48-26/h18-26,28-32,34,41-42,45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30+,31-,32-,34+,36-,37-,38-/m1/s1
InChI Key:
NKLGIWNNVDPGCA-ZDYKNUMJSA-N
SMILES:
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](C(=O)[C@@H]([C@@H]2[C@]1(C)OC(=O)O2)C)C)(C)O
UNII:
4H3125L82R
Properties
Complexity:
1300  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
18  
Defined Bond Stereocenter Count:
0
Exact Mass:
759.441g/mol
Formal Charge:
0
Heavy Atom Count:
53  
Hydrogen Bond Acceptor Count:
15  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
759.931g/mol
Monoisotopic Mass:
759.441g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
189A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.1  
Literature
Title Journal
Comparative efficacy of new investigational agents against Helicobacter pylori. Alimentary pharmacology & therapeutics 20010401
Properties